One observational study conducted in the UK showed a 0.51% reduction in HbA1c and a 5.8-kg reduction in weight, with one in six patients discontinuing insulin after 26 weeks of exenatide-insulin combination therapy
Weight loss is important, but clinicians may also consider A1C, blood pressure, lipids, cardiovascular risk, liver fat, tolerability, medication interactions, quality of life, and long-term maintenance
Employer-sponsored health plans are not required to cover obesity treatment
They both contain the active ingredient semaglutide
Claims such as good source and excellent source of fiber may be achieved in products
So why does it matter which one you use, and how do you even get access to the most affordable option legally